Who are we ?

We are a complementary team with cross-functional skills, particularly in -omics data analysis, molecular biology, clinical data analysis and nephrologists.


Geoffroy POULET, CEO

Engineer in biotechnology and PhD in molecular biology, Geoffroy Poulet developed a strong knowledge on microfluidic analytical techniques such as NGS & digital PCR. Specialist of circulating-cell-free DNA, he implemented newly biomarkers dedicated to translational cancer research. With his 4 years’ experience in large diagnostic and pharmaceutical groups, Geoffroy Poulet acquired skills to guide the development strategy of CGenetix. Driving team element, pro-active with excellent negotiation power, Geoffroy Poulet is also responsible for the establishment of new clinical partnerships.



With a degree in General Engineering and a masters in strategy and management from ESSEC Business School, Amine developed a profound expertise in the management of complexes projects and organizations transformation in his career as a strategy consultant including for healthcare company. Amine developed a wide range of skills, throughout his experience: Complexes projects scoping, roadmaps building, transformation plans, operational and financial risk assessment. As CGenetix co-founders, Amine Mohammadi will take the lead of the operational and the business development department and contribute to help CGenetix to grow up.


With an Engineer R&D degree in Industrial Biotechnology finished at Newcastle University, Yoan came back in Paris as Research Engineer and achieve a PhD in Immunology and Cancerology at Sorbonne University focusing on digital pathology of lung cancer. He worked for more than 5 years in collaboration with hospital clinician and the AstraZeneca’s Cancer US branch. While managing a research team, he has acquired strong expertise on lung cancer immunology, clinical data, and transcriptomic analysis. His wish to make research that benefit the people are the values that drives him to join CGenetix as CTO.



Holder of a bachelor’s in molecular biology and biostatistics, and a master’s in computer science applied to human health from the university Paris-Saclay, Thomas has strong skills in life sciences data analysis. After a 3 years’ experience in a Finnish company as bioinformatician, where he was responsible for the development of NGS bioinformatic pipelines, web applications and data processing methods, having strongly developed both his technical and project management skills, he joined CGenetix to take the lead of the IT section.

Strategic Advisor Board


Allan holds an MBA from Laval University in Quebec and is a graduate of ESIEE in biotechnology. He is the CEO of VitaDX, a MedTech company working on an in vitro diagnosis medical device dedicated to the early diagnosis of bladder cancer. He has been leading this start-up project since 2013, and brings, as Managing Director, his skills to guide and implement the company's strategic decisions. He also has experience as a business creator and as a support for innovative start-ups in the field of health.

Jean-Michel Carles, President Eurobio-Scientific

Jean-Michel Carles, President Eurobio-Scientific Jean-Michel is an experienced diagnostic company director for 15 years. He began his career as a sales engineer for 4 years then regional sales manager for 3 years at Bayer Diagnostics acquired by Siemens. He then held the position of Product Manager, then Sales Director for 13 years and 1 year of Germany Business Unit Director for 12 months, at Biomedical Diagnostics (BMD) which became TheraDiag. From 2006 to 2010, he held the position of Commercial Director and then General Manager at Eurobio from 2006 to 2010 after the takeover of the company (7M€ 40 people 100K EBITDA). His company merged in 2017 with Diaxonhit (Ingen). To date, Jean-Michel manages an ETI of 184 M€ in 2021 with 180 and which is present in 9 countries with subsidiaries.

Kidney Medical Advisor Board


Dany Anglicheau is Full Professor of Nephrology at Université de Paris. He is the head of the Department of Nephrology and Kidney Transplantation of Necker University Hospital, Paris, France and is directing the kidney transplant program. He has received several awards including the 2007 Young Investigator Award of the French Society of Nephrology. He is a member of the French Speaking Society of Transplantation, the French Society of Nephrology-Dialysis-Transplantation, and the American Society of Nephrology. He has published over 210 peer-reviewed articles mainly on kidney transplantation amongst others in various high-impact journal.


Pierre Galichon is associate professor of Nephrology at Sorbonne University. He is also an attending Physician in Sorbonne University's kidney transplantation department in Pitié-Salpêtrière Hospital, Paris, France. His research lab at INSERM focuses on mechanisms of renal repair. His research focuses on non-invasive biomarkers of kidney allograft dysfunction, and on the mechanisms of renal repair and resilience after acute kidney injury. He is the principal investigator of preclinical studies on various models of acute kidney injury, and of a government funded study on the prevention of delayed graft function by nicotinamide in kidney transplant recipients.

Our supports